trending Market Intelligence /marketintelligence/en/news-insights/trending/gUylmT030aW6Vax3lMbpPw2 content esgSubNav
In This List

Novelion Therapeutics adds director; 2 others step down

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Novelion Therapeutics adds director; 2 others step down

Novelion Therapeutics Inc. appointed Mark DiPaolo to its board.

DiPaolo is with Sarissa Capital Management LP as a partner and general counsel.

In addition, Geoffrey Cox and Jorge Plutzky stepped down from the company's board.